← Back to Search

HGNS Therapy Participants for Obstructive Sleep Apnea

N/A
Recruiting
Led By Phillip LoSavio, MD, MS
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline and after hgns implant, acclimation, and tuning at 3 month post-op
Awards & highlights

Study Summary

The purpose of this study is to determine if the treatment of Obstructive sleep apnea (OSA) by hypoglossal nerve stimulation (HGNS) will alter glucose metabolism. The study team will also determine if the treatment of Obstructive sleep apnea (OSA) by (hypoglossal nerve stimulation) HGNS will alter predictors of cardiovascular outcomes.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and after hgns implant, acclimation, and tuning at 3 month post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and after hgns implant, acclimation, and tuning at 3 month post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic variability
Mean systolic BP (daytime and nocturnal)
Secondary outcome measures
Hemoglobin A1c
Insulin levels
Mean norepinephrine levels
+12 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: HGNS Therapy ParticipantsExperimental Treatment1 Intervention
Individuals with sleep apnea treated by HGNS therapy.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,747 Total Patients Enrolled
Phillip LoSavio, MD, MSPrincipal InvestigatorUniversity of Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation
2024. "Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06317701.
All > Chicago > Milwaukee
~20 spots leftby Apr 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top